(Q53173190)

12 May 2018

title

Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma. (English)

1 reference

12 May 2018

1 reference

6

1 reference

12 May 2018

author name string

Adeel R Seyal

1

1 reference

12 May 2018

Fernanda D Gonzalez-Guindalini

2

1 reference

12 May 2018

Atilla Arslanoglu

3

1 reference

12 May 2018

Carla B Harmath

4

1 reference

12 May 2018

Robert J Lewandowski

5

1 reference

12 May 2018

Vahid Yaghmai

7

1 reference

12 May 2018

language of work or name

English

0 references

publication date

19 June 2015

1 reference

12 May 2018

published in

Hepatology

1 reference

12 May 2018

volume

62

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

1111-1121

1 reference

12 May 2018

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy

cites work

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

21 January 2018

1 reference

Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres.

21 January 2018

1 reference

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

21 January 2018

1 reference

Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.

21 January 2018

1 reference

Design and endpoints of clinical trials in hepatocellular carcinoma.

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma

21 January 2018

1 reference

Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

21 January 2018

1 reference

EASL and mRECIST responses are independent predictors of survival in hepatocellular carcinoma patients treated with cryoablation

21 January 2018

1 reference

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).

21 January 2018

1 reference

Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis

21 January 2018

1 reference

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma

21 January 2018

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

21 January 2018

1 reference

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.

21 January 2018

1 reference

Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

21 January 2018

1 reference

Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria.

21 January 2018

1 reference

Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital.

21 January 2018

1 reference

Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

21 January 2018

1 reference

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

7 January 2021

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

1 reference

7 January 2021

Multiphase hepatic CT with a multirow detector CT scanner

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.27915

1 reference

12 May 2018

PubMed ID

25999236

1 reference

12 May 2018